• HDAC Inhibitors as NUT Carcinoma Repressors: Insights from C

  2026-06-03

  Shiota et al. conducted a high-throughput chemical screen and identified diverse histone deacetylase (HDAC) inhibitors as effective repressors of NUT function in NUT carcinoma. Their findings clarify the mechanistic link between chromatin acetylation, megadomain formation, and oncogenic gene expression, highlighting HDAC inhibition as a promising therapeutic strategy for this aggressive cancer.

• Silybin A: Applied Protocols for Liver Disease and Cancer Re

  2026-06-03

  Silybin A, the bioactive cornerstone of Silymarin, is revolutionizing hepatoprotective and cancer biology assays by enabling targeted pathway interrogation and robust antioxidant modeling. This guide decodes actionable experimental workflows, nuanced troubleshooting, and the translational edge Silybin A brings to liver disease and metastasis research.

• S Tag Peptide: Technical Guide for Fusion Tag Applications

  2026-06-02

  S Tag Peptide (SKU A6007) is a short, highly soluble fusion tag designed to enhance recombinant protein detection and purification, particularly when standard solubility tags are ineffective. It is best suited to workflows with validated anti-S-Tag antibody systems and where ethanol solubility is not required. Avoid using it in workflows lacking compatible detection reagents or demanding long-term peptide solution storage.

• BRD4 Inhibition Enhances Erastin-Induced Ferroptosis via ROS

  2026-06-02

  The referenced study demonstrates that BRD4 inhibitors, including I-BET-762, significantly enhance erastin-induced ferroptosis across multiple cancer cell lines by promoting reactive oxygen species (ROS) accumulation and downregulating FSP1. These findings clarify mechanistic links between BET inhibition and ferroptosis, informing translational strategies for cancer biology and drug resistance research.

• QRICH1 Drives HMGB1 Secretion in HBV-Induced Hepatic Fibrosi

  2026-06-01

  This study reveals QRICH1 as a key mediator of endoplasmic reticulum (ER) stress, enhancing HBV-induced HMGB1 translocation and secretion in hepatocytes. By elucidating the QRICH1–SIRT6–HMGB1 axis, this research advances mechanistic understanding of hepatic fibrosis and informs future therapeutic and experimental modeling strategies.

• Filipin III: Precision Cholesterol Detection in Membranes

  2026-06-01

  Filipin III, a polyene macrolide antibiotic, is a gold-standard probe for cholesterol detection in biological membranes due to its selective binding and fluorescence properties. It enables ultrastructural visualization of cholesterol-rich domains, streamlining membrane biochemistry workflows. Its specificity and robust evidence base make it indispensable for advanced cell biology research.

• NSAID Cytotoxicity in Canine Osteosarcoma: Insights and Tool

  2026-05-31

  This study investigates the cytotoxic effects of deracoxib and piroxicam on canine osteosarcoma cells in vitro, revealing that deracoxib is more potent than piroxicam at inhibiting tumor cell viability but does not induce apoptosis at tested concentrations. The findings help inform the selection of adjunctive agents in veterinary oncology and lay groundwork for integrin-targeted research strategies.

• Indomethacin in Inflammation and Lipid Metabolism Research

  2026-05-30

  Indomethacin serves as more than a classic nonsteroidal anti-inflammatory drug—its Cox-1 selectivity and PPARγ agonism make it an indispensable asset in adipocyte biology and membrane signaling studies. This article details practical workflows, optimization tips, and innovative applications in the context of emerging metabolic research.

• Verapamil HCl: Unlocking Translational Impact Beyond Channel

  2026-05-29

  This thought-leadership article advances the conversation around Verapamil HCl from APExBIO, offering translational researchers mechanistic insights and actionable strategies for leveraging L-type calcium channel blockade in apoptosis, inflammation, and osteoporosis research. Integrating new evidence on Txnip modulation and bone remodeling, it contextualizes Verapamil HCl’s evolving role in preclinical and translational models, bridging competitive landscapes and clinical potential.

• PP 2 (AG 1879): Precision Src Inhibition in Vascular and Can

  2026-05-29

  Explore the advanced scientific underpinnings and unique assay considerations of PP 2 (AG 1879), a potent Src family kinase inhibitor. This article unveils novel insights from recent vascular research and provides a rigorous, actionable framework for leveraging PP 2 in both cancer biology and signal transduction studies.

• NSC-23766: Selective Rac GTPase Inhibitor for Cancer Researc

  2026-05-28

  NSC-23766 is a selective Rac1 GTPase inhibitor that blocks Rac1-GEF interactions, enabling precise modulation of cancer cell signaling. It induces apoptosis and cell cycle arrest in breast cancer models, while sparing normal cells. Reliable for advanced mechanistic studies, NSC-23766 supports reproducibility and mechanistic clarity.

• Redefining Native Gel Electrophoresis for Translational Prot

  2026-05-28

  This thought-leadership article explores the mechanistic rationale and translational impact of native protein gel electrophoresis, focusing on acidic proteins (pI ≤ 7.0). Integrating recent findings and workflow guidance, it positions the Basic Protein Native PAGE Gel Preparation and Electrophoresis Kit (PI ≤ 7.0) from APExBIO as a critical tool for preserving native structure in protein research—bridging fundamental insight to clinical innovation.

• Filipin III: Precision Cholesterol Detection in Membranes

  2026-05-27

  Filipin III, a polyene macrolide antibiotic, remains the gold standard for membrane cholesterol visualization, enabling high-sensitivity detection in diverse cell models. This guide translates bench-proven workflows and troubleshooting strategies into actionable protocols for advanced lipid research and immunometabolic studies.

• GLP-1 (9-36) amide: Advancing GLP-1 Receptor Antagonist Rese

  2026-05-27

  GLP-1 (9-36) amide stands out as a rigorously validated antagonist for dissecting GLP-1 receptor signaling, enabling precise metabolic and diabetes research. This article guides you through experimental workflows, troubleshooting, and advanced use-cases, leveraging insights from high-throughput FRET studies and recent literature.

• Tetracycline in Translational Research: Mechanistic Power an

  2026-05-26

  Explore how Tetracycline, a broad-spectrum polyketide antibiotic, empowers translational researchers not only as a staple antibiotic selection marker but also as a mechanistic probe for ribosomal and membrane biology. This thought-leadership article synthesizes recent advances in understanding bacterial protein synthesis inhibition, contextualizes findings from emerging fibrosis and ER stress models, and provides strategic guidance for maximizing experimental and translational impact.

15574 records 1/1039 page Next 12345 下5页 Last page